Publisher
Springer Science and Business Media LLC
Reference87 articles.
1. Mulder DJ, Noble AJ, Justinich CJ, Duffin JM. A tale of two diseases: the history of inflammatory bowel disease. J Crohn’s & Colitis. 2014;8(5):341–8.
2. Chen C, Hartzema AG, Xiao H, Wei YJ, Chaudhry N, Ewelukwa O, et al. Real-world pattern of biologic use in patients with inflammatory bowel disease: treatment persistence, switching, and importance of concurrent immunosuppressive therapy. Inflamm Bowel Dis. 2019;25(8):1417–27.
3. Xu F, W A, Liu Y, Lu H, Greenlund KJ. Hospitalizations for inflammatory bowel disease among Medicare fee-for-service beneficiaries — United States, 1999–2017. [cited 2019 68:1134–1138].
4. Xu F, et al. Hospitalizations for inflammatory bowel disease among Medicare fee-for-service beneficiaries - United States, 1999-2017. MMWR Morb Mortal Wkly Rep. 2019;68(49):1134–8.
5. Ma C, Moran GW, Benchimol EI, Targownik LE, Heitman SJ, Hubbard JN, et al. Surgical rates for Crohn’s disease are decreasing: a population-based time trend analysis and validation study. Am J Gastroenterol. 2017;112(12):1840–8.